DMTX

Dimension Therapeutics

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Dimension Therapeutics, Inc. market cap is N/A.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Dimension Therapeutics, Inc. 52 week high is N/A as of September 17, 2025.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Dimension Therapeutics, Inc. 52 week low is N/A as of September 17, 2025.

Dimension Therapeutics, Inc. stock price today is $5.98.

Dimension Therapeutics, Inc. stock price yesterday was $5.98.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Dimension Therapeutics, Inc.’s P/E ratio is None.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Dimension Therapeutics, Inc. P/B ratio is None.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Dimension Therapeutics, Inc.'s EBITDA is N/A.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Dimension Therapeutics, Inc. 50-day moving average is N/A.

Dimension Therapeutics, Inc. has 74 employees.